UPMC Hillman Cancer Center Passavant North is a clinical research site located in Cranberry Township, Pennsylvania, United States 16066.
Crixeo Clinical Trials Trust Score: 11/100 (FAILING). This profile has not yet been claimed by the site owner.
UPMC Hillman Cancer Center Passavant North has participated in 2 clinical trials with 1 currently active.
Therapeutic areas: HER2 Positive Breast Cancer, Triple Negative Breast Cancer.
Sponsors: Seagen, a wholly owned subsidiary of Pfizer, NSABP Foundation Inc.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Pennsylvania · View every site in Cranberry Township
Trust Score: 11/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
UPMC Hillman Cancer Center Passavant North has a Crixeo Trust Score of 11/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
UPMC Hillman Cancer Center Passavant North has 2 clinical trials on record, with 1 currently active. Their work covers HER2 Positive Breast Cancer, Triple Negative Breast Cancer.
UPMC Hillman Cancer Center Passavant North has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.